Gennex Laboratories Ltd Quarterly Results

Gross Sales

34.18

40.33

37.71

31.55

28.32

Excise Duty

0

0

0

0

0

Net Sales

34.18

40.33

37.71

31.55

28.32

Other Operating Income

0

0

2.3

1.83

0

Other Income

2.28

3.83

0

0

2.47

Total Income

36.45

44.16

40.01

33.38

30.79

Total Expenditure

29.11

38.46

32.85

25.93

24.09

PBIDT

7.35

5.7

7.15

7.45

6.69

Interest

0.98

1.2

0.84

0.22

0.73

PBDT

6.37

4.5

6.31

7.24

5.96

Depreciation

0.5

0.54

0.5

1.11

0.45

Minority Interest Before NP

0

0

0

0

0

Tax

0.85

0.83

0.75

0.75

0.85

Deferred Tax

0

0.05

0

0

0

Reported Profit After Tax

5.02

3.07

5.07

5.37

4.66

Minority Interest After NP

0.42

0.75

0.42

0.55

0.24

Net Profit after Minority Interest

4.59

2.32

4.64

4.83

4.42

Extra-ordinary Items

0

-0.12

0

0

0

Adjusted Profit After Extra-ordinary item

4.59

2.44

4.64

4.83

4.42

EPS (Unit Curr.)

0.22

0.14

0.22

0.21

0.19

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

23.14

22.74

22.74

22.74

22.74

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

21.5

14.13

18.96

23.61

23.62

PBDTM(%)

18.63

11.15

16.73

22.94

21.04

PATM(%)

14.68

7.61

13.44

17.02

16.45